Balancing between immunity and tolerance: An interplay between dendritic cells, regulatory T cells, and effector T cells

Journal of Leukocyte Biology

Volumn 82, Issue 6, 2007, Pages 1365-1374

  Cools, Nathalie ^a   Ponsaerts, Peter ^b   Van Tendeloo, Viggo F I ^b   Berneman, Zwi N ^b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b NONE

Author keywords

Antigen presenting cells; Co stimulation; Cytokines; DC based therapies

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHLOROQUINE; COLECALCIFEROL; CORTICOSTEROID; CYCLOSPORIN A; ESTROGEN; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; N METHYLTRYPTOPHAN; POLYINOSINIC POLYCYTIDYLIC ACID; RAPAMYCIN; TOLL LIKE RECEPTOR 3; TRANSFORMING GROWTH FACTOR BETA; TRIPTOLIDE; TRYPTOPHAN DERIVATIVE; TUMOR ANTIGEN;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELL THERAPY; CELLULAR IMMUNITY; DENDRITIC CELL; EFFECTOR CELL; HELPER CELL; HUMAN; IMMUNITY; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW;

ANIMALS; CELL DIFFERENTIATION; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; T-LYMPHOCYTES, REGULATORY; TISSUE THERAPY;

EID: 35549004528     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0307166     Document Type: Review

References (146)

1. Steinman, R. M., Turley, S., Mellman, I., Inaba, K. (2000) The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191, 411-416.
2. Liu, Y. J. (2001) Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106, 255-258.
3. Shortman, K., Liu, Y. J. (2002) Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2, 151-161.
4. Briere, F., Bendriss-Vermare, N., Delale, T., Burg, S., Corbet, C., Rissoan, M. C., Chaperot, L., Plumas, J., Jacob, M. C., Trinchieri, G., et al. (2002) Origin and filiation of human plasmacytoid dendritic cells. Hum. Immunol. 63, 1081-1093.
5. Bendriss-Vermare, N., Barthelemy, C., Durand, I., Bruand, C., Dezutter-Dambuyant, C., Moulian, N., Berrih-Aknin, S., Caux, C., Trinchieri, G., Briere, F. (2001) Human thymus contains IFN-alpha-producing CD11c(-), myeloid CD11c(+), and mature interdigitating dendritic cells. J. Clin. Invest. 107, 835-844.
6. Kronin, V., Suss, G., Winkel, K., Shortman, K. (1997) The regulation of T cell responses by a subpopulation of CD8+DEC205+ murine dendritic cells. Adv. Exp. Med. Biol. 417, 239-248.
7. Kronin, V, Vremec, D., Winkel, K., Classon, B. J., Miller, R. G., Mak, T. W., Shortman, K., Suss, G. (1977) Are CD8+ dendritic cells (DC) veto cells? The role of CD8 on DC in DC development and in the regulation of CD4 and CD8 T cell responses. Int. Immunol. 1997; 9, 1061-1064.
8. Suss, G., Shortman, K. (1996) A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. Exp. Med. 183, 1789-1796.
9. Belz, G. T., Behrens, G. M., Smith, C. M., Miller, J. F., Jones, C., Lejon, K., Fathman, C. G., Mueller, S. N., Shortman, K., Carbone, F. R., et al. (2002) The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. Med. 196, 1099-1104.
10. Belz, G. T., Heath, W. R., Carbone, F. R. (2002) The role of dendritic cell subsets in selection between tolerance and immunity. Immunol. Cell Biol. 80, 463-468.
11. Liu, K., Iyoda, T., Saternus, M., Kimura, Y., Inaba, K., Steinman, R. M. (2002) Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196, 1091-1097.
12. Fujimoto, N., Ishida, H., Nakamura, I., Ogasawara, K., Itoh, Y. (2003) Quantities of interleukin-12p40 in mature CD8alpha negative dendritic cells correlate with strength of TCR signal and determine Th cell development. Microbiol. Immunol. 47, 1017-1024.
13. O'Connell, P. J., Son, Y. I., Giermasz, A., Wang, Z., Logar, A. J., Thomson, A. W., Kalinski, P. (2003) Type-1 polarized nature of mouse liver CD8alpha- and CD8alpha+ dendritic cells: tissue-dependent differences offset CD8alpha-related dendritic cell heterogeneity. Eur. J. Immunol. 33, 2007-2013.
14. Dalod, M., Salazar-Mather, T. P., Malmgaard, L., Lewis, C., Asselin-Paturel, C., Briere, F., Trinchieri, G., Biron, C. A. (2002) Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 195, 517-528.
15. Kadowaki, N., Ho, S., Antonenko, S., Malefyt, R. W., Kastelein, R. A., Bazan, F., Liu, Y. J. (2001) Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194, 863-869.
16. Barchet, W., Cella, M., Colonna, M. (2005) Plasmacytoid dendritic cells - virus experts of innate immunity. Semin. Immunol. 17, 253-261.
17. Kadowaki, N., Liu, Y. J. (2002) Natural type I interferon-producing cells as a link between innate and adaptive immunity. Hum. Immunol. 63, 1126-1132.
18. Kadowaki, N., Antonenko, S., Lau, J. Y., Liu, Y. J. (2000) Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J. Exp. Med. 192, 219-226.
19. Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., Liu, Y. J. (1999) The nature of the principal type 1 interferon-producing cells in human blood. Science 284, 1835-1837.
20. Steinman, R. M., Hawiger, D., Nussenzweig, M. C. (2003) Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711.
21. Jonuleit, H., Schmitt, E., Steinbrink, K., Enk, A. H. (2001) Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 22, 394-400.
22. Mahnke, K., Schmitt, E., Bonifaz, L., Enk, A. H., Jonuleit, H. (2002) Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol. Cell Biol. 80, 477-483.
23. Martin, P., Del Hoyo, G. M., Anjuere, F., Arias, C. F., Vargas, H. H., Fernandez, L., Parrillas, V., Ardavin, C. (2002) Characterization of a new subpopulation of mouse CD8alpha+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood 100, 383-390.
24. Wilson, N. S., El Sukkari, D., Villadangos, J. A. (2004) Dendritic cells constitutively present self-antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis. Blood 103, 2187-2195.
25. Steinbrink, K., Wolfl, M., Jonuleit, H., Knop, J., Enk, A. H. (1997) Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159, 4772-4780.
26. Lutz, M. B., Schuler, G. (2002) Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23, 445-449.
27. Schwartz, R. H., Mueller, D. L., Jenkins, M. K., Quill, H. (1989) T-cell clonal anergy. Cold Spring Harb. Symp. Quant. Biol. 54, 605-610.
28. Schwartz, R. H. T cell anergy. (2003) Annu. Rev. Immunol. 21, 305-334.
29. Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., Nussenzweig, M. C. (2001) Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194, 769-779.
30. Dhodapkar, M. V., Steinman, R. M., Krasovsky, J., Munz, C., Bhardwaj, N. (2001) Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193, 233-238.
31. Dhodapkar, M. V., Steinman, R. M. (2002) Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood 100, 174-177.
32. Jonuleit, H., Giesecke-Tuettenberg, A., Tuting, T., Thurner-Schuler, B., Stuge, T. B., Paragnik, L., Kandemir, A., Lee, P. P., Schuler, G., Knop, J., et al. (2001) A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection. Int. J. Cancer 93, 243-251.
33. Henri, S., Vremec, D., Kamath, A., Waithman, J., Williams, S., Benoist, C., Burnham, K., Saeland, S., Handman, E., Shortman, K. (2001) The dendritic cell populations of mouse lymph nodes. J. Immunol. 167, 741-748.
34. Ruedl, C., Koebel, P., Bachmann, M., Hess, M., Karjalainen, K. (2000) Anatomical origin of dendritic cells determines their life span in peripheral lymph nodes. J. Immunol. 165, 4910-4916.
35. Ip, W. K., Lau, Y. L. (2004) Distinct maturation of, but not migration between, human monocyte-derived dendritic cells upon ingestion of apoptotic cells of early or late phases. J. Immunol. 173, 189-196.
36. Huang, F. P., Platt, N., Wykes, M., Major, J. R., Powell, T. J., Jenkins, C. D., MacPherson, G. G. (2000) A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191, 435-444.
37. Scheinecker, C., McHugh, R., Shevach, E. M., Germain, R. N. (2002) Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 196, 1079-1090.
38. Verhasselt, V., Vosters, O., Beuneu, C., Nicaise, C., Stordeur, P., Goldman, M. Induction of FOXP3-expressing regulatory CD4pos T cells by human mature autologous dendritic cells (2004). Eur. J. Immunol. 34, 762-772.
39. Akbari, O., DeKruyff, R. H., Umetsu, D. T. (2001) Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2, 725-731.
40. Schulz, O., Edwards, A. D., Schito, M., Aliberti, J., Manickasingham, S., Sher, A., Reis e Sousa, C. (2000) CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 13, 453-462.
41. Vieira, P. L., de Jong, E. C., Wierenga, E. A., Kapsenberg, M. L., Kalinski, P. (2000) Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J. Immunol. 164, 4507-4512.
42. Kalinski, P., Hilkens, C. M., Snijders, A., Snijdewint, F. G., Kapsenberg, M. L. (1997) Dendritic cells, obtained from peripheral blood precursors in the presence of PGE2, promote Th2 responses. Adv. Exp. Med. Biol. 417, 363-367.
43. Kalinski, P., Vieira, P. L., Schuitemaker, J. H., de Jong, E. C., Kapsenberg, M. L. (2001) Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 97, 3466-3469.
44. Faries, M. B., Bedrosian, I., Xu, S., Koski, G., Roros, J. G., Moise, M. A., Nguyen, H. Q., Engels, F. H., Cohen, P. A., Czerniecki, B. J. (2001) Calcium signaling inhibits interleukin-12 production and activates CD83(+) dendritic cells that induce Th2 cell development. Blood 98, 2489-2497.
45. Jonuleit, H., Schmitt, E., Steinbrink, K., Enk, A. H. (2001) Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 22, 394-400.
46. Adler, A. J., Marsh, D. W., Yochum, G. S., Guzzo, J. L., Nigam, A., Nelson, W. G., Pardoll, D. M. (1998) CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J. Exp. Med. 187, 1555-1564.
47. Lutz, M. B., Kukutsch, N. A., Menges, M., Rossner, S., Schuler, G. (2000) Culture of bone marrow cells in GM-CSF plus high doses of lipopolysaccharide generates exclusively immature dendritic cells which induce alloantigen-specific CD4 T cell anergy in vitro. Eur. J. Immunol. 30, 1048-1052.
48. Heath, W. R., Carbone, F. R. (2001) Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 19, 47-64.
49. Finkelman, F. D., Lees, A., Birnbaum, R., Gause, W. C., Morris, S. C. (1996) Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J. Immunol. 157, 1406-1414.
50. Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C., Steinman, R. M. (2002) Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196, 1627-1638.
51. Bonifaz, L. C., Bonnyay, D. P., Charalambous, A., Darguste, D. I., Fujii, S., Soares, H., Brimnes, M. K., Moltedo, B., Moran, T. M., Steinman, R. M. (2004) In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199, 815-824.
52. Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R., et al. (2002) Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297, 1867-1870.
53. Mellor, A. L., Munn, D. H. (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4, 762-774.
54. Kurts, C., Heath, W. R., Kosaka, H., Miller, J. F., Carbone, F. R. (1998) The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J. Exp. Med. 188, 415-420.
55. Albert, M. L., Jegathesan, M., Darnell, R. B. (2001) Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat. Immunol. 2, 1010-1017.
56. Braun, D., Longman, R. S., Albert, M. L. (2005) A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood 106, 2375-2381.
57. Bergwelt-Baildon, M. S., Popov, A., Saric, T., Chemnitz, J. M., Classen, S., Stoffel, M. S., Fiore, F., Roth, U., Beyer, M., Debey, S., Wickenhauser, C., Hanisch, F. G., Schultze, J. L. (2006) CD25 and indoleamine 2,3-dioxygenase are upregulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo:additional mechanisms of T cell inhibition. Blood 108, 228-257.
58. Zhang, M., Tang, H., Guo, Z., An, H., Zhu, X., Song, W., Guo, J., Huang, X., Chen, T., Wang, J., et al. (2004) Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells. Nat. Immunol. 5, 1124-1133.
59. Qian, C., An, H., Yu, Y., Liu, S., Cao, X. (2007) TLR agonists induce regulatory dendritic cells to recruit Th1 cells via preferential IP-10 secretion and inhibit Th1 proliferation. Blood 109, 3308-3315.
60. Jonuleit, H., Schmitt, E. (2003) The regulatory T cell family: distinct subsets and their interrelations. J. Immunol. 171, 6323-6327.
61. Banchereau, J., Steinman, R. M. (1998) Dendritic cells and the control of immunity. Nature 392, 245-252.
62. Steinman, R. M., Nussenzweig, M. C. (2002) Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 99, 351-358.
63. Jonuleit, H., Schmitt, E., Schuler, G., Knop, J., Enk, A. H. (2000) Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192, 1213-1222.
64. Levings, M. K., Gregori, S., Tresoldi, E., Cazzaniga, S., Bonini, C., Roncarolo, M. G. (2005) Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 105, 1162-1169.
65. Wakkach, A., Fournier, N., Brun, V., Breittmayer, J. P., Cottrez, F., Groux, H. (2003) Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18, 605-617.
66. Manavalan, J. S., Rossi, P. C., Vlad, G., Piazza, F., Yarilina, A., Cortesini, R., Mancini, D., Suciu-Foca, N. (2003) High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl. Immunol. 11, 245-258.
67. Colonna, M., Trinchieri, G., Liu, Y. J. (2004) Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5, 1219-1226.
68. Lundqvist, A., Palmborg, A., Pavlenko, M., Levitskaya, J., Pisa, P. (2005) Mature dendritic cells induce tumor-specific type 1 regulatory T cells. J. Immunother. 28, 229-235.
69. Yamazaki, S., Iyoda, T., Tarbell, K., Olson, K., Velinzon, K., Inaba, K., Steinman, R. M. (2003) Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198, 235-247.
70. Yamazaki, S., Inaba, K., Tarbell, K. V., Steinman, R. M. (2006) Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity. Immunol. Rev. 212, 314-329.
71. Banerjee, D. K., Dhodapkar, M. V., Matayeva, E., Steinman, R. M., Dhodapkar, K. M. (2006) Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs. in vitro and after injection of cytokine-matured DCs in myeloma patients. Blood 108, 2655-2661.
72. Fehervari, Z., Sakaguchi, S. (2004) Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells. Int. Immunol. 16, 1769-1780.
73. Kretschmer, K., Apostolou, I., Hawiger, D., Khazaie, K., Nussenzweig, M. C., von Boehmer, H. (2005) Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6, 1219-1227.
74. Chakraborty, N. G., Chattopadhyay, S., Mehrotra, S., Chhabra, A., Mukherji, B. (2004) Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma. Hum. Immunol. 65, 794-802.
75. Reis e Sousa, C. (2006) Dendritic cells in a mature age. Nat. Rev. Immunol. 6, 476-483.
76. Langrish, C. L., McKenzie, B. S., Wilson, N. J., de Waal, M. R., Kastelein, R. A., Cua, D. J. (2004) IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 202, 96-105.
77. Reis e Sousa, C. (2001) Dendritic cells as sensors of infection. Immunity 14, 495-498.
78. Kaisho, T., Akira, S. (2001) Bug detectors. Nature 414, 701-703.
79. Kopp, E., Medzhitov, R. (2003) Recognition of microbial infection by Toll-like receptors. Curr. Opin. Immunol. 15, 396-401.
80. Sporri, R., Reis e Sousa, C. (2003) Newly activated T cells promote maturation of bystander dendritic cells but not IL-12 production. J. Immunol. 171, 6406-6413.
81. Greenfield, E. A., Nguyen, K. A., Kuchroo, V. K. (1998) CD28/B7 costimulation: a review. Crit. Rev. Immunol. 18, 389-418.
82. Lenschow, D. J., Walunas, T. L., Bluestone, J. A. (1996) CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14, 233-258.
83. Salomon, B., Lenschow, D. J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A., Bluestone, J. A. (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431-440.
84. Greenwald, R. J., Boussiotis, V. A., Lorsbach, R. B., Abbas, A. K., Sharpe, A. H. (2001) CTLA-4 regulates induction of anergy in vivo. Immunity 14, 145-155.
85. Curtsinger, J. M., Schmidt, C. S., Mondino, A., Lins, D. C., Kedl, R. M., Jenkins, M. K., Mescher, M. F. (1999) Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J. Immunol. 162, 3256-3262.
86. Curtsinger, J. M., Valenzuela, J. O., Agarwal, P., Lins, D., Mescher, M. F. (2005) Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174, 4465-4469.
87. Curtsinger, J. M., Gerner, M. Y., Lins, D. C., Mescher, M. F. (2007) Signal 3 availability limits the CD8 T cell response to a solid tumor. J. Immunol. 178, 6752-6760.
88. Curtsinger, J. M., Lins, D. C., Mescher, M. F. (2003) Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J. Exp. Med. 197, 1141-1151.
89. Pasare, C., Medzhitov, R. (2003) Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299, 1033-1036.
90. Oberg, H. H., Wesch, D., Grussel, S., Rose-John, S., Kabelitz, D. (2006) Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+. Int. Immunol. 18, 555-563.
91. Kubo, T., Hatton, R. D., Oliver, J., Liu, X., Elson, C. O., Weaver, C. T. (2004) Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells. J. Immunol. 173, 7249-7258.
92. King, I. L., Segal, B. M. (2005) Cutting edge: IL-12 induces CD4+. J. Immunol. 175, 641-645.
93. de Jong, E. C., Smits, H. H., Kapsenberg, M. L. (2005) Dendritic cell-mediated T cell polarization. Springer Semin. Immunopathol. 26, 289-307.
94. Miller, S. D., McMahon, E. J., Schreiner, B., Bailey, S. L. (2007) Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis. Ann. N. Y. Acad. Sci. 1103, 179-191.
95. Pearce, E. J., Kane, C. M., Sun, J. (2006) Regulation of dendritic cell function by pathogen-derived molecules plays a key role in dictating the outcome of the adaptive immune response. Chem. Immunol. Allergy 90, 82-90.
96. Xu, S., Koldovsky, U., Xu, M., Wang, D., Fitzpatrick, E., Son, G., Koski, G., Czerniecki, B. J. (2006) High-avidity antitumor T-cell generation by toll receptor 8-primed, myeloid- derived dendritic cells is mediated by IL-12 production. Surgery 140, 170-178.
97. Napolitani, G., Rinaldi, A., Bertoni, F., Sallusto, F., Lanzavecchia, A. (2005) Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6, 769-776.
98. Higgins, S. C., Lavelle, E. C., McCann, C., Keogh, B., McNeela, E., Byrne, P., O'Gorman, B., Jarnicki, A., McGuirk, P., Mills, K. H. (2003) Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J. Immunol. 171, 3119-3127.
99. Reithmeier-Rost, D., Bierschenk, S., Filippova, N., Schroder-Braunstein, J., Sing, A. (2004) Yersinia V antigen induces both TLR. Cell. Immunol. 231, 63-74.
100. Grabbe, S., Bruvers, S., Gallo, R. L., Knisely, T. L., Nazareno, R., Granstein, R. D. (1991) Tumor antigen presentation by murine epidermal cells. J. Immunol. 146, 3656-3661.
101. Flamand, V., Sornasse, T., Thielemans, K., Demanet, C., Bakkus, M., Bazin, H., Tielemans, F., Leo, O., Urbain, J., Moser, M. (1994) Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol. 24, 605-610.
102. Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Flament, C., Tenza, D., Ricciardi-Castagnoli, P., Raposo, G., Amigorena, S. (1998) Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4, 594-600.
103. Banchereau, J., Palucka, A. K. (2005) Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 5, 296-306.
104. Su, Z., Dannull, J., Heiser, A., Yancey, D., Pruitt, S., Madden, J., Coleman, D., Niedzwiecki, D., Gilboa, E., Vieweg, J. (2003) Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells. Cancer Res. 63, 2127-2133.
105. Nair, S. K., Morse, M., Boczkowski, D., Cumming, R. I., Vasovic, L., Gilboa, E., Lyerly, H. K. (2002) Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells. Ann. Surg. 235, 540-549.
106. Rosenberg, S. A., Dudley, M. E. (2004) Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes. Proc. Natl. Acad. Sci. USA 101, Suppl 2, 14639-14645.
107. Maker, A. V., Phan, G. Q., Attia, P., Yang, J. C., Sherry, R. M., Topalian, S. L., Kammula, U. S., Royal, R. E., Haworth, L. R., Levy, C., et al. (2005) Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study. Ann. Surg. Oncol. 12, 1005-1016.
108. Attia, P., Phan, G. Q., Maker, A. V., Robinson, M. R., Quezado, M. M., Yang, J. C., Sherry, R. M., Topalian, S. L., Kammula, U. S., Royal, R. E., et al. (2005) Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. J. Clin. Oncol. 23, 6043-6053.
109. Brody, J. D., Engleman, E. G. (2004) DC-based cancer vaccines: lessons from clinical trials. Cytotherapy 6, 122-127.
110. Nencioni, A., Brossart, P. (2004) Cellular immunotherapy with dendritic cells in cancer: current status. Stem Cells 22, 501-513.
111. Larsson, M., Fonteneau, J. F., Somersan, S., Sanders, C., Bickham, K., Thomas, E. K., Mahnke, K., Bhardwaj, N. (2001) Efficiency of cross presentation of vaccinia virus-derived antigens by human dendritic cells. Eur. J. Immunol. 31, 3432-3442.
112. Somersan, S., Larsson, M., Fonteneau, J. F., Basu, S., Srivastava, P., Bhardwaj, N. (2001) Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells. J. Immunol. 167, 4844-4852.
113. Smits, E. L., Ponsaerts, P., Van de Velde, A. L., Van Driessche, A., Cools, N., Lenjou, M., Nijs, G., Van Bockstaele, D. R., Berneman, Z. N., Van Tendeloo, V. F. (2007) Proinflammatory response of human leukemic cells to dsRNA transfection linked to activation of dendritic cells. Leukemia, 21, 1691-1699.
114. Van Duin, D., Medzhitov, R., Shaw, A. C. (2006) Triggering TLR signaling in vaccination. Trends Immunol. 27, 49-55.
115. Zobywalski, A., Javorovic, M., Frankenberger, B., Pohla, H., Kremmer, E., Bigalke, I., Schendel, D. J. (2007) Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70 (Online). J. Transl. Med. 5, 18.
116. Ponsaerts, P., Van den Bosch, G., Cools, N., Van Driessche, A., Nijs, G., Lenjou, M., Lardon, F., Van Broeckhoven, C., Van Bockstaele, D. R., Berneman, Z. N., et al. (2002) Messenger RNA electroporation of human monocytes, followed by rapid in vitro differentiation, leads to highly stimulatory antigen-loaded mature dendritic cells. J. Immunol. 169, 1669-1675.
117. Cools, N., Van Tendeloo, V. F., Smits, E., Lenjou, M., Nijs, G., Van Bockstaele, D. R., Berneman, Z. N., Ponsaerts, P. (2007) Immunosuppression induced by immature dendritic cells is mediated by TGF-β and IL-10 double-positive adaptive regulatory CD4+CD25-FOXP3-T cells. J. Cell. Mol. Med., Epub ahead of print.
118. Van den Bosch, G. A., Van Gulck, E., Ponsaerts, P., Nijs, G., Lenjou, M., Apers, L., Kint, I., Heyndrickx, L., Vanham, G., Van Bockstaele, D. R., et al. (2006) Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells. J. Immunother. 29, 512-523.
119. Van den Bosch, G. A., Ponsaerts, P., Nijs, G., Lenjou, M., Vanham, G., Van Bockstaele, D. R., Berneman, Z. N., Van Tendeloo, V. F. (2005) Ex vivo induction of viral antigen-specific CD8 T cell responses using mRNA-electroporated CD40-activated B cells. Clin. Exp. Immunol. 139, 458-467.
120. Kalinski, P., Mailliard, R. B., Giermasz, A., Zeh, H. J., Basse, P., Bartlett, D. L., Kirkwood, J. M., Lotze, M. T., Herberman, R. B. (2005) Natural killer-dendritic cell cross-talk in cancer immunotherapy. Expert Opin. Biol. Ther. 5, 1303-1315.
121. Kalinski, P., Giermasz, A., Nakamura, Y., Basse, P., Storkus, W. J., Kirkwood, J. M., Mailliard, R. B. (2005) Helper role of NK cells during the induction of anticancer responses by dendritic cells. Mol. Immunol. 42, 535-539.
122. Baxevanis, C. N., Voutsas, I. F., Tsitsilonis, O. E., Gritzapis, A. D., Sotiriadou, R., Papamichail, M. (2000) Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor. J. Immunol. 164, 3902-3912.
123. Wang, J. C., Livingstone, A. M. (2003) Cutting edge: CD4+ T cell help can be essential for primary CD8+ T cell responses in vivo. J. Immunol. 171, 6339-6343.
124. Schoenberger, S. P., Toes, R. E., van der Voort, E. I., Offringa, R., Melief, C. J. (1998) T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393, 480-483.
125. Prasad, S. J., Farrand, K. J., Matthews, S. A., Chang, J. H., McHugh, R. S., Ronchese, F. (2005) Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4+CD25+ regulatory T cells. J. Immunol. 174, 90-98.
126. Dannull, J., Su, Z., Rizzieri, D., Yang, B. K., Coleman, D., Yancey, D., Zhang, A., Dahm, P., Chao, N., Gilboa, E., et al. (2005) Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J. Clin. Invest. 115, 3623-3633.
127. Corinti, S., Albanesi, C., la Sala, A., Pastore, S., Girolomoni, G. (2001) Regulatory activity of autocrine IL-10 on dendritic cell functions. J. Immunol. 166, 4312-4318.
128. Steinbrink, K., Graulich, E., Kubsch, S., Knop, J., Enk, A. H. (2002) CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 99, 2468-2476.
129. Sato, K., Yamashita, N., Matsuyama, T. (2002) Human peripheral blood monocyte-derived interleukin-10-induced semi-mature dendritic cells induce anergic CD4(+) and CD8(+) T cells via presentation of the internalized soluble antigen and cross-presentation of the phagocytosed necrotic cellular fragments. Cell. Immunol. 215, 186-194.
130. Sato, K., Yamashita, N., Baba, M., Matsuyama, T. (2003) Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood 101, 3581-3589.
131. Muller, G., Muller, A., Tuting, T., Steinbrink, K., Saloga, J., Szalma, C., Knop, J., Enk, A. H. (2002) Interleukin-10-treated dendritic cells modulate immune responses of naive and sensitized T cells in vivo. J. Invest. Dermatol. 119, 836-841.
132. Zhang, M., Wang, Q., Liu, Y., Sun, Y., Ding, G., Fu, Z., Min, Z., Zhu, Y., Cao, X. (2004) Effective induction of immune tolerance by portal venous infusion with IL-10 gene-modified immature dendritic cells leading to prolongation of allograft survival. J. Mol. Med. 82, 240-249.
133. Menges, M., Rossner, S., Voigtlander, C., Schindler, H., Kukutsch, N. A., Bogdan, C., Erb, K., Schuler, G., Lutz, M. B. (2002) Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195, 15-21.
134. Voigtlander, C., Rossner, S., Cierpka, E., Theiner, G., Wiethe, C., Menges, M., Schuler, G., Lutz, M. B. (2006) Dendritic cells matured with TNF can be further activated in vitro and after subcutaneous injection in vivo which converts their tolerogenicity into immunogenicity. J. Immunother. 29, 407-415.
135. Xiao, B. G., Huang, Y. M., Link, H. (2006) Tolerogenic dendritic cells: the ins and outs of outcome. J. Immunother. 29, 465-471.
136. Imazeki, I., Matsuzaki, J., Tsuji, K., Nishimura, T. (2006) Immunomodulating effect of vitamin D3 derivatives on type-1 cellular immunity. Biomed. Res. 27, 1-9.
137. Lyakh, L. A., Sanford, M., Chekol, S., Young, H. A., Roberts, A. B. (2005) TGF-beta and vitamin D3 utilize distinct pathways to suppress IL-12 production and modulate rapid differentiation of human monocytes into CD83+ dendritic cells. J. Immunol. 174, 2061-2070.
138. Gregori, S., Giarratana, N., Smiroldo, S., Uskokovic, M., Adorini, L. (2002) A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 51, 1367-1374.
139. Gregori, S., Casorati, M., Amuchastegui, S., Smiroldo, S., Davalli, A. M., Adorini, L. (2001) Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167, 1945-1953.
140. Liu, Q., Chen, T., Chen, G., Shu, X., Sun, A., Ma, P., Lu, L., Cao, X. (2007) Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-kappaB pathways. Mol. Immunol. 44, 2686-2696.
141. Liu, Q., Chen, T., Chen, G., Li, N., Wang, J., Ma, P., Cao, X. (2006) Immunosuppressant triptolide inhibits dendritic cell-mediated chemoattraction of neutrophils and T cells through inhibiting Stat3 phosphorylation and NF-kappaB activation. Biochem. Biophys. Res. Commun. 345, 1122-1130.
142. Manavalan, J. S., Kim-Schulze, S., Scotto, L., Naiyer, A. J., Vlad, G., Colombo, P. C., Marboe, C., Mancini, D., Cortesini, R., Suciu-Foca, N. (2004) Alloantigen specific CD8+. Int. Immunol. 16, 1055-1068.
143. Liu, J., Liu, Z., Witkowski, P., Vlad, G., Manavalan, J. S., Scotto, L., Kim-Schulze, S., Cortesini, R., Hardy, M. A., Suciu-Foca, N. (2004) Rat CD8+ FOXP3+ T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection. Transpl. Immunol. 13, 239-247.
144. Mondino, A., Khoruts, A., Jenkins, M. K. (1996) The anatomy of T-cell activation and tolerance. Proc. Natl. Acad. Sci. USA 93, 2245-2252.
145. Reinhardt, R. L., Jenkins, M. K. (2003) Whole-body analysis of T cell responses. Curr. Opin. Immunol. 15, 366-371.
146. Figdor, C. G., de Vries, I. J., Lesterhuis, W. J., Melief, C. J. (2004) Dendritic cell immunotherapy: mapping the way. Nat. Med. 10, 475-480.